PO3 0.00% 22.0¢ purifloh limited

Ann: FRG Trials on Tuberculosis, page-253

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 310 Posts.
    lightbulb Created with Sketch. 107
    The beauty about TB is that it’s not very profitable to treat and cure, the industry and the health care systems around the world would love the FRG because it’s all about preventing it and if they can eliminate 95%-99% of new cases by the year 2035 it’s a massive win/win situation for everyone... shareholders make multibaggers and get dividends, the company provides more jobs for the economy, sickness and illness is down a substatial rate, a lot of airborne sicknesses are prevented, the government spends less money on the health care system, people have a better quality of life and we will be rich
 
watchlist Created with Sketch. Add PO3 (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
0.000(0.00%)
Mkt cap ! $7.078M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
PO3 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.